Why the study?
Does labetalol effectively and safely treat hypertension in elderly patients?
Does labetalol effectively and safely treat hypertension in elderly patients?
Labetalol at a low dose (200 mg daily) is an effective and well-tolerated treatment for hypertension in elderly patients.
Supports low-dose labetalol for long-term hypertension control in elderly patients; extends RCT evidence of sustained efficacy and tolerability.
The response of elderly hypertensive patients to labetalol, possessing alpha- and beta-blocking properties, was studied. The dosage was first titrated out and assessed in a double-blind cross-over trial. Altogether 24 patients were treated for one year. The dosage established during the titration period maintained its efficacy. In most cases 200 mg labetalol daily gave satisfactory result. The side-effects were few. The only reason for discontinuance of the drug was gastrointestinal discomfort. Because of the low dosage, the typical side-effects of beta-blockade were lacking and alpha-blockade seemed to be well tolerated. The normal precautions in the treatment of elderly hypertensive patients should be observed.
No takes yet. Share an insight, caveat, or question.
Eisalo et al. (1982) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: